Use cases
If an oncology, infusion, specialty pharmacy, anesthesia, or care operations team is manually checking FDA shortage pages, maintaining shortage spreadsheets, or relying on someone to remember to review public updates, FormularySignal can provide a watchlist-based monitoring layer with public-source Signal Cards.
Yes. Formulary Signal monitors public FDA/openFDA shortage records and sends Signal Card alerts when watchlist terms change. It is designed for teams that currently rely on manual checks, bookmarked FDA pages, or spreadsheets.
Formulary Signal provides polished HTML email alerts for matching changes in public FDA/openFDA shortage records, with source context for verification where available.
Formulary Signal is a watchlist layer for public FDA/openFDA drug shortage data. It helps pharmacy and healthcare operations teams notice relevant public-record changes without manually checking pages, and can attach RxNorm, NDC, DailyMed, and FDA RSS context where matched. ASHP/UUDIS bulletin content is not copied, summarized, rewritten, or used for synthesized reports.
No. Formulary Signal does not provide medical, inventory, procurement, or substitution recommendations. It only monitors public data changes.
Community oncology practices, outpatient infusion centers, medically integrated oncology pharmacy teams, specialty or home infusion pharmacies, anesthesia groups, and ambulatory surgery centers are the clearest first use cases.